Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial

BACKGROUND: The Shexiang Baoxin Pill (MUSKARDIA) has been used for treating coronary artery disease (CAD) and angina for more than 30 years in China. Nevertheless, methodologically sound trials on the use of MUSKARDIA in CAD patients are scarce. The aim of the study is to determine the effects of MU...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Chin Med J (Engl)
Prif Awduron: Ge, Jun-Bo, Fan, Wei-Hu, Zhou, Jing-Min, Shi, Hai-Ming, Ji, Fu-Sui, Wu, Yang, Zhao, Yu-Lan, Qian, Jun, Jin, Yuan-Zhe, Liu, Ying-Wu, Wang, Sheng-Huang, He, Sheng-Hu, Yang, Ping, Wu, Jie, Lu, Feng, Hou, Zi-Shan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Lippincott Williams & Wilkins 2021
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7817287/
https://ncbi.nlm.nih.gov/pubmed/33273369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000001257
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg